Weiner HL - Search Results

1

Oral tolerance to insulin and the insulin B-chain: cell lines and cytokine patterns.

Maron R, Blogg NS, Polanski M, Hancock W, Weiner HL. Maron R, et al. Among authors: weiner hl. Ann N Y Acad Sci. 1996 Feb 13;778:346-57. doi: 10.1111/j.1749-6632.1996.tb21142.x. Ann N Y Acad Sci. 1996. PMID: 8610988 No abstract available.

2

Mechanisms of oral tolerance by MHC peptides.

Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Sayegh MH, et al. Among authors: weiner hl. Ann N Y Acad Sci. 1996 Feb 13;778:338-45. doi: 10.1111/j.1749-6632.1996.tb21141.x. Ann N Y Acad Sci. 1996. PMID: 8610987 Review.

3

Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens.

Friedman A, al-Sabbagh A, Santos LM, Fishman-Lobell J, Polanski M, Das MP, Khoury SJ, Weiner HL. Friedman A, et al. Among authors: weiner hl. Chem Immunol. 1994;58:259-90. Chem Immunol. 1994. PMID: 8011155 Review.

4

Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.

Polanski M, Melican NS, Zhang J, Weiner HL. Polanski M, et al. Among authors: weiner hl. J Autoimmun. 1997 Aug;10(4):339-46. doi: 10.1006/jaut.1997.0148. J Autoimmun. 1997. PMID: 9237797

5

Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice.

Maron R, Palanivel V, Weiner HL, Harn DA. Maron R, et al. Among authors: weiner hl. Clin Immunol Immunopathol. 1998 Apr;87(1):85-92. doi: 10.1006/clin.1997.4506. Clin Immunol Immunopathol. 1998. PMID: 9576014

6

Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines.

Weiner HL, Gonnella PA, Slavin A, Maron R. Weiner HL, et al. Res Immunol. 1997 Oct-Dec;148(8-9):528-33. doi: 10.1016/s0923-2494(98)80146-6. Res Immunol. 1997. PMID: 9588831 Review. No abstract available.

7

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

Maron R, Melican NS, Weiner HL. Maron R, et al. Among authors: weiner hl. J Autoimmun. 1999 Jun;12(4):251-8. doi: 10.1006/jaut.1999.0278. J Autoimmun. 1999. PMID: 10330296

8

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

Balashov KE, Rottman JB, Weiner HL, Hancock WW. Balashov KE, et al. Among authors: weiner hl. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6873-8. doi: 10.1073/pnas.96.12.6873. Proc Natl Acad Sci U S A. 1999. PMID: 10359806 Free PMC article.

9

Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.

Garcia G, Komagata Y, Slavin AJ, Maron R, Weiner HL. Garcia G, et al. Among authors: weiner hl. J Autoimmun. 1999 Nov;13(3):315-24. doi: 10.1006/jaut.1999.0320. J Autoimmun. 1999. PMID: 10550219

10

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.

Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ. Weiner HL, et al. Ann Neurol. 2000 Oct;48(4):567-79. Ann Neurol. 2000. PMID: 11026440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

849 results

Search Page

Filters